SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-024225
Filing Date
2021-05-03
Accepted
2021-05-03 16:02:18
Documents
1
Period of Report
2021-04-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4164
  Complete submission text file 0001213900-21-024225.txt   5629
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GEMINI THERAPEUTICS, INC. ONE KENDALL SQUARE, BUILDING 300 CAMBRIDGE MA 02139
Business Address
Strapps Walter (Reporting) CIK: 0001849041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 21883459